Vermox 100mg chewable tablets

Land: Vereinigtes Königreich

Sprache: Englisch

Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)

Wirkstoff:

Mebendazole

Verfügbar ab:

Janssen-Cilag Ltd

ATC-Code:

P02CA01

INN (Internationale Bezeichnung):

Mebendazole

Dosierung:

100mg

Darreichungsform:

Chewable tablet

Verabreichungsweg:

Oral

Klasse:

No Controlled Drug Status

Verschreibungstyp:

Valid as a prescribable product

Produktbesonderheiten:

BNF: 05050100; GTIN: 5012674076224

Gebrauchsinformation

PACKAGE LEAFLET: INFORMATION FOR THE USER
VERMOX
® 100 MG TABLETS
Mebendazole
Vermox is a registered trademark
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE.
•
Keep this leaflet. You may need to read it again
•
If you have any further questions, ask your doctor or pharmacist
•
This medicine has been prescribed for you. Do not pass it on to
others. It
may harm them, even if their symptoms are the same as yours
•
If you get side effects and they become serious or if you notice any
side
effects not listed in this leaflet, please tell your doctor or
pharmacist
IN THIS LEAFLET
1.
What Vermox tablets are and what they are used for
2.
Before you use Vermox tablets
3.
How to use Vermox tablets
4.
Possible side effects
5.
How to store Vermox tablets
6.
Further information
7.
Further advice regarding worms
1. WHAT VERMOX TABLETS ARE AND WHAT THEY ARE USED FOR
The name of your medicine is Vermox 100 mg tablets (referred to as
Vermox
tablets in this leaflet). Vermox tablets contain a medicine called
mebendazole. It
is one of a group of medicines called ‘anthelmintics’.
Vermox tablets are used to treat worm infections of the gut such as:
•
threadworms (pinworms)
•
other common worm infections (such as whipworm, roundworm,
hookworm)
You or your child has been advised to take Vermox tablets because you
have
a worm infection. Worms can infect anyone. It does not necessarily
mean that
your hygiene is poor.
2. BEFORE YOU USE VERMOX TABLETS
DO NOT USE VERMOX TABLETS IF:
•
You are allergic to anything in Vermox tablets (listed in section 6
below)
•
Your child is under 2 years old
Do not use this medicine if any of the above applies to you. If you
are not sure,
talk to your doctor or pharmacist before using Vermox tablets.
TAKING OTHER MEDICINES
Please tell your doctor or pharmacist if you are taking or have
recently taken any
other medicines. This includes medicines that you buy without a
prescription,
herbal medicines, dietary supplements or vitamins.
In particular tell your doctor or

Fachinformation

OBJECT 1
VERMOX 100 MG TABLETS
Summary of Product Characteristics Updated 21-Nov-2014 | Janssen-Cilag
Ltd
1. Name of the medicinal product
Vermox 100 mg tablets
2. Qualitative and quantitative composition
Each tablet contains 100 mg of mebendazole.
Excipients: Each tablet also contains 0.06 mg of sunset yellow (E110).
For a full list of excipients, see section 6.1
3. Pharmaceutical form
Tablet.
Flat, circular, pale orange tablets with “Me/100“ on one side and
“JANSSEN“ on the other.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of _Trichuris trichuria_ (whipworm), _Enterobius
vermicularis_ (pinworm or threadworm),
_Ascaris lumbricoides_ (roundworm), _Ancylostoma duodenale_ (common
hookworm), _Necator americanus_
(American hookworm) in single or mixed gastrointestinal infestations.
There is no evidence that Vermox Tablets are effective in the
treatment of cysticercosis.
4.2 Posology and method of administration
Adults and children over 2 years:
For the control of trichuriasis, ascariasis and hookworm infections,
one tablet twice a day for three
consecutive days.
For the control of enterobiasis a single tablet is administered. It is
highly recommended that a second
tablet is taken after two weeks, if re-infection is suspected.
Tablets may be chewed or swallowed whole. Crush the tablet before
giving it to a young child. Always
supervise a child while they are taking this medicine.
Method of Administration
Oral use.
4.3 Contraindications
Vermox is contraindicated in pregnancy and in patients who have shown
hypersensitivity to the product
or any components.
4.4 Special warnings and precautions for use
Not recommended in the treatment of children under 2 years.
A case-control study of a single outbreak of Stevens-Johnson syndrome
/toxic epidermal necrolysis
(SJS/TEN) suggested a possible association with the concomitant use of
metronidazole with
mebendazole. Although there are no additional data on this potential
interaction, concomitant use of
mebendazole and metronidazole should be avoided